Current Rating Overview
On 06 Nov 2025, Prevest Denpro Ltd's rating was revised to Sell from a previous Hold status, accompanied by a significant decline in its Mojo Score from 51 to 31. This rating reflects a cautious stance on the stock, signalling that investors should consider reducing exposure or avoiding new positions given prevailing market and company-specific conditions.
It is important to note that while the rating change occurred several months ago, the data and performance indicators presented here are up to date as of 21 March 2026, ensuring that the evaluation is based on the most recent financial and market developments.
How the Stock Looks Today: Quality Assessment
As of 21 March 2026, Prevest Denpro Ltd holds an average quality grade. The company’s operating profit has grown at a modest annual rate of 12.49% over the past five years, which indicates some growth but not at a pace that would inspire strong confidence. The return on capital employed (ROCE) for the half year ending December 2025 stands at a relatively low 22.79%, signalling limited efficiency in generating profits from capital invested.
Additionally, the debtors turnover ratio is at 6.53 times, which is on the lower side, suggesting slower collection of receivables and potential working capital concerns. These factors combined contribute to the average quality rating, reflecting a business that is stable but not excelling in operational metrics.
Valuation Considerations
Currently, the company’s valuation is considered expensive. With a price-to-book value ratio of 4, Prevest Denpro Ltd trades at a premium relative to its book value. Despite this, the stock is priced at a discount compared to its peers’ average historical valuations, which may offer some relative value.
The return on equity (ROE) is 17%, which is respectable but does not fully justify the elevated valuation multiple. The PEG ratio of 1.4 indicates that the stock’s price is somewhat aligned with its earnings growth, but the premium valuation suggests investors are paying for expectations that may not be fully realised given the company’s recent performance.
Financial Trend and Performance
The financial trend for Prevest Denpro Ltd is currently flat. The company reported flat results in the December 2025 half year, with no significant improvement in profitability or operational efficiency. Over the past year, the stock has delivered a negative return of -15.90%, underperforming the broader BSE500 index across multiple time frames including one year, three months, and three years.
While profits have risen by 17% over the last year, this has not translated into positive stock price performance, reflecting investor concerns about sustainability and growth prospects. The long-term growth remains subdued, and the company’s operating profit growth rate does not indicate a strong upward trajectory.
Technical Analysis
From a technical standpoint, Prevest Denpro Ltd is rated bearish. The stock has experienced consistent downward pressure, with recent price movements showing a 1-day gain of 1.3% but declines of -6.64% over one week and -20.63% over one month. The six-month performance is particularly weak, with a drop of -32.43%, signalling a negative momentum trend.
This bearish technical grade suggests that the stock is facing selling pressure and lacks strong support levels, which may deter short-term investors and traders from initiating new positions until a clearer reversal pattern emerges.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
What This Rating Means for Investors
The Sell rating on Prevest Denpro Ltd indicates that the stock is currently not favoured for accumulation or holding by investors seeking capital appreciation or stable returns. The combination of average quality, expensive valuation, flat financial trends, and bearish technical signals suggests that the stock faces multiple headwinds.
Investors should be cautious and consider the risks associated with the company’s subdued growth prospects and recent underperformance relative to broader market indices. The rating advises a defensive approach, potentially reducing exposure or avoiding new purchases until there are clear signs of operational improvement and valuation realignment.
That said, the company’s microcap status and sector positioning in healthcare services may offer niche opportunities for investors with a higher risk tolerance who are willing to monitor developments closely.
Summary of Key Metrics as of 21 March 2026
To recap, the latest data shows:
- Mojo Score: 31.0 (Sell Grade)
- Operating profit growth rate (5 years): 12.49% annually
- ROCE (HY): 22.79%
- Debtors turnover ratio (HY): 6.53 times
- ROE: 17%
- Price to Book Value: 4
- PEG ratio: 1.4
- Stock returns: 1Y -15.90%, 6M -32.43%, 3M -20.08%
These figures collectively underpin the current cautious stance on the stock.
Looking Ahead
Investors should continue to monitor Prevest Denpro Ltd’s quarterly results and sector developments closely. Any improvement in operational efficiency, earnings growth, or valuation metrics could warrant a reassessment of the rating. Until then, the Sell recommendation remains a prudent guide for portfolio management.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
